摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-N,6-N-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]naphthalene-1,6-disulfonamide

中文名称
——
中文别名
——
英文名称
1-N,6-N-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]naphthalene-1,6-disulfonamide
英文别名
——
1-N,6-N-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]naphthalene-1,6-disulfonamide化学式
CAS
——
化学式
C28H26N6O4S2
mdl
——
分子量
574.7
InChiKey
IAHOBEQSPQESET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    40
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    158
  • 氢给体数:
    4
  • 氢受体数:
    8

文献信息

  • COMPOSITIONS AND METHODS FOR BONE FORMATION AND MODELING
    申请人:ENZO Biochem, Inc.
    公开号:US20130172332A1
    公开(公告)日:2013-07-04
    The present disclosure is directed to methods of identifying a compound that binds to or interacts with a protein receptor involved in bone formation. Specifically, the disclosure is directed to methods of identifying a compound that regulates a Wnt pathway in a cell by binding to or interacting with cavities in proteins such as LRP5, LRP 6 and/or frizzled receptor and interfering with receptor binding to other proteins in a Wnt pathway. The present disclosure is further directed to methods and compositions that comprise an identified compound for treating or preventing a disease in a mammal in which Wnt pathway suppression plays a role.
  • US8367822B2
    申请人:——
    公开号:US8367822B2
    公开(公告)日:2013-02-05
  • US8969339B2
    申请人:——
    公开号:US8969339B2
    公开(公告)日:2015-03-03
查看更多